Altshuler Shaham’s Axonics, Inc. Common Stock AXNX Stock Holding History

Altshuler Shaham’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-371	Closed	-$26K	–	626
2022 Q3	$26K	Buy	+371	New	+$25.6K	﹤0.01%	345

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Altshuler Shaham's AXNX Position: Q4 2022 in Review

Altshuler Shaham sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2022, closing a stake of 371 shares — an estimated $26K sold.

Altshuler Shaham first reported a position in AXNX in Q3 2022 and held it in 1 quarter. The position peaked at $26K in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q4 2022.

Altshuler Shaham reported no remaining Axonics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Altshuler Shaham sold 371 Axonics, Inc. Common Stock shares in Q4 2022, an estimated $26K.
Altshuler Shaham first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Altshuler Shaham's Axonics, Inc. Common Stock position peaked at $26K in Q3 2022.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2022.

Based on Altshuler Shaham's 13F filing for Q4 2022, filed 15 Feb 2023.